SCHEMBL8287181

SCHEMBL8287181

Cc1cc(C(N)=O)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.46
TDP1 Q9NUW8 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPT P10636 7/20 0.42
PDE4B Q07343 2/20 0.42
PDE4A P27815 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
LMNA P02545 2/20 0.41
POLB P06746 1/20 0.40
GAA P10253 4/20 0.39
MAPK1 P28482 2/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 3/20 0.38
ATM Q13315 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GFER P55789 1/20 0.38
RCE1 Q9Y256 1/20 0.38
BRD4 O60885 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285149 0.91 PDE11A (0.47) PDE11ATDP1L3MBTL1MAPTLMNA
SCHEMBL8287471 0.88 PDE11A (0.45) PDE11ATDP1L3MBTL1MAPTLMNA
SCHEMBL8286439 0.88 MAPT (0.52) PDE11ATDP1L3MBTL1MAPTLMNA
SCHEMBL8286434 0.87 PDE11A (0.44) PDE11ATDP1L3MBTL1MAPTLMNA
SCHEMBL8287425 0.85 PDE11A (0.43) PDE11ATDP1L3MBTL1MAPTLMNA
SCHEMBL8286414 0.85 CSF1R (0.47) PDE11ATDP1L3MBTL1MAPTPDE4B
SCHEMBL8287397 0.85 PDE11A (0.46) PDE11AMAPTPDE4BPDE4APDE4C
SCHEMBL8286440 0.84 PDE11A (0.48) PDE11ATDP1MAPTLMNAPOLB
SCHEMBL8287154 0.84 PDE11A (0.48) PDE11ATDP1MAPTLMNAPOLB
SCHEMBL8285163 0.84 POLB (0.50) PDE11ATDP1MAPTLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed